Literature DB >> 16276955

Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci.

Trisha Kreman1, Jianfang Hu, Jean Pottinger, Loreen A Herwaldt.   

Abstract

OBJECTIVES: To identify infection control policies and practices used by long-term-care facilities (LTCFs) in Iowa for residents with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant enterococci (VRE), and to estimate the prevalence of residents known to have these organisms.
DESIGN: Survey.
SETTING: LTCFs in Iowa from December 2002 through March 2003.
RESULTS: Of the 429 LTCFs in Iowa, 331 (77%) responded to the survey. The estimated prevalence of residents known to have MRSA was 13.4 per 1,000 and that of residents known to have VRE was 2.3 per 1,000. Facilities owned by the government or those with an average of more than 86 occupied beds were more likely to have residents known to have MRSA and VRE (P = .002 and .007, respectively). Of the responding facilities, 7.3% acknowledged that they refused to accept individuals known to have MRSA and 16.9% acknowledged that they refused to accept those known to have VRE. Facilities in large communities (population, > 100,000) were least likely to deny admission to an individual known to have either MRSA or VRE (P = .05). Most facilities reported adhering to the national guidelines, but fewer than half (44.7%) of the respondents had heard of the Iowa Antibiotic Resistance Task Force's guidelines regarding residents with MRSA or VRE.
CONCLUSIONS: Many LTCFs in Iowa care for residents known to have MRSA or VRE, but some refuse to admit these individuals. Infection control personnel and public health officials should work together to educate LTCF staff so that residents receive proper care and resistant organisms do not spread within this setting.

Entities:  

Mesh:

Year:  2005        PMID: 16276955     DOI: 10.1086/502498

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

1.  Isolation Precautions Use for Multidrug-Resistant Organism Infection in Nursing Homes.

Authors:  Catherine C Cohen; Andrew Dick; Patricia W Stone
Journal:  J Am Geriatr Soc       Date:  2017-02-17       Impact factor: 5.562

2.  Infection prevention and control in nursing homes: a qualitative study of decision-making regarding isolation-based practices.

Authors:  Catherine Crawford Cohen; Monika Pogorzelska-Maziarz; Carolyn T A Herzig; Eileen J Carter; Ragnhildur Bjarnadottir; Patricia Semeraro; Jasmine L Travers; Patricia W Stone
Journal:  BMJ Qual Saf       Date:  2015-05-22       Impact factor: 7.035

3.  How are nursing homes cleaned? Results of a survey of 6 nursing homes in Southeast Michigan.

Authors:  Aya Saeb; Lona Mody; Kristen Gibson
Journal:  Am J Infect Control       Date:  2017-09-25       Impact factor: 2.918

4.  Healthcare-associated pathogens and nursing home policies and practices: results from a national survey.

Authors:  Zhiqiu Ye; Dana B Mukamel; Susan S Huang; Yue Li; Helena Temkin-Greener
Journal:  Infect Control Hosp Epidemiol       Date:  2015-03-23       Impact factor: 3.254

5.  Methicillin-resistant Staphylococcus aureus burden in nursing homes associated with environmental contamination of common areas.

Authors:  Courtney R Murphy; Samantha J Eells; Victor Quan; Diane Kim; Ellena Peterson; Loren G Miller; Susan S Huang
Journal:  J Am Geriatr Soc       Date:  2012-06-05       Impact factor: 5.562

6.  Effect of daily chlorhexidine bathing on hospital-acquired infection.

Authors:  Michael W Climo; Deborah S Yokoe; David K Warren; Trish M Perl; Maureen Bolon; Loreen A Herwaldt; Robert A Weinstein; Kent A Sepkowitz; John A Jernigan; Kakotan Sanogo; Edward S Wong
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

7.  SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

8.  In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.

Authors:  Shveta Rani Singh; Alfred E Bacon; David C Young; Kimberly A Couch
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

9.  Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility.

Authors:  Pierre Tattevin; Binh An Diep; Michael Jula; Françoise Perdreau-Remington
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  Nursing home characteristics associated with methicillin-resistant Staphylococcus aureus (MRSA) Burden and Transmission.

Authors:  Courtney R Murphy; Victor Quan; Diane Kim; Ellena Peterson; Matthew Whealon; Grace Tan; Kaye Evans; Hildy Meyers; Michele Cheung; Bruce Y Lee; Dana B Mukamel; Susan S Huang
Journal:  BMC Infect Dis       Date:  2012-10-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.